Raven-Symoné recalls being pushed to alter her body in order to get a television show at the tender age of 15.

SamanTree Medical, a leader in oncologic surgical imaging innovation, today announced promising results from the SHIELD study ...

Avril Mathie - who has clocked up a record of 8-1-1 since switching to the fight game after winning the Miss Swimsuit USA crown - believes the cosmetic procedure will pay off in the ring.

Meta-analysis of three trials found that immediate breast surgery in women over 70 cut breast cancer death rates in half ...

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast, according to 6-year data from the OlympiA trial.

AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast ...

The findings from the study demonstrated a substantial decrease in reoperation rates when the Histolog scanner was utilised.

Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.

The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...

Interim overall survival (OS) analyses at 31% maturity in patients with ESR1 mutations, and 23% maturity among all patients, ...

Adjuvant Lynparza remains beneficial for patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, study results have shown.